Allosteric regulation Knowledge-Based Practice

Questions

1. 1.

   How does the binding of a positive allosteric effector (allosteric activator) enhance the catalytic activity of an enzyme?

   • A) It binds to a non-catalytic regulatory site on the enzyme, inducing a structural alteration that stabilizes the high-affinity conformation of the active site.
   • B) It enters the catalytic pocket and covalently cross-links with the substrate to directly decrease the activation energy of the reaction.
   • C) It functions as an inorganic cofactor that directly substitutes for the catalytic amino acid side chains within the active site.
   • D) It prevents product release from the active site, thereby shifting the overall chemical equilibrium of the reaction forward.
2. 2.

   In metabolic pathways regulated by feedback inhibition, how does the accumulating end product typically function as an allosteric regulator?

   • A) It binds reversibly to a regulatory site distinct from the active site on an early enzyme, reducing its catalytic activity.
   • B) It binds directly to the active site of the first enzyme, competing with the initial substrate for catalytic turnover.
   • C) It forms an irreversible covalent bond with the catalytic residues of each intermediate enzyme in the pathway.
   • D) It permanently denatures the enzyme that catalyzes the committed step of the pathway through proteolysis.
3. 3.

   Many allosteric enzymes oscillate between active and inactive conformations. Which of the following describes the specific effect of an allosteric inhibitor on this structural equilibrium?

   • A) It binds to a regulatory site and stabilizes the inactive conformation, decreasing catalytic activity.
   • B) It binds to the active site and locks the enzyme into its active conformation, preventing product release.
   • C) It forms covalent bonds between catalytic subunits, shifting the equilibrium permanently toward the active state.
   • D) It cleaves regulatory domains from the protein, causing irreversible denaturation of the active site.
4. 4.

   In multimeric enzymes, cooperativity is considered a specialized form of allosteric regulation. Which of the following events characterizes this mechanism?

   • A) An allosteric effector covalently bonds with an active site, permanently altering the primary sequence of the enzyme.
   • B) A downstream product competes directly with the substrate for the same catalytic pocket on a single subunit.
   • C) A regulatory molecule binds exclusively to the enzyme-substrate complex, preventing the release of product molecules.
   • D) A substrate molecule binding to one active site induces a conformational change that stabilizes the active state in all other subunits.
5. 5.

   Which of the following best describes the mechanism of allosteric regulation in enzymes?

   • A) An effector molecule directly competes with the substrate by occupying the catalytic active site.
   • B) A regulatory molecule binds to a site distinct from the active site, inducing a conformational change that alters enzyme activity.
   • C) A chemical agent forms irreversible covalent bonds with peptide bonds, permanently denaturing the protein.
   • D) A prosthetic group acts as a permanent electron donor within the catalytic pocket during substrate conversion.

Answers and step-by-step solutions appear after you finish the test.